Terms: = Thyroid cancer AND PTEN, MMAC1, 5728, MGC11227, PTEN1, MHAM, P60484, BZS, ENSG00000171862
479 results:
1. Multiple and hereditary renal tumors: a review for radiologists.
Corral de la Calle MÁ; Encinas de la Iglesia J; Fernández Pérez GC; Fraino A; Repollés Cobaleda M
Radiologia (Engl Ed); 2024; 66(2):132-154. PubMed ID: 38614530
[TBL] [Abstract] [Full Text] [Related]
2. Knowledge Mapping of Cowden Syndrome: a Bibliometric Analysis.
Peng Q; Duan N; Wang X; Wang WM
Chin J Dent Res; 2024 Mar; 27(1):75-82. PubMed ID: 38546522
[TBL] [Abstract] [Full Text] [Related]
3. Deep response to a combination of mTOR inhibitor temsirolimus and dual immunotherapy of nivolumab/ipilimumab in poorly differentiated thyroid carcinoma with
Oh Y; Park JH; Djunadi TA; Shah Z; Chung LI; Chae YK
Front Endocrinol (Lausanne); 2024; 15():1304188. PubMed ID: 38356955
[TBL] [Abstract] [Full Text] [Related]
4. thyroid dysfunction caused by exposure to environmental endocrine disruptors and the underlying mechanism: A review.
He J; Xu J; Zheng M; Pan K; Yang L; Ma L; Wang C; Yu J
Chem Biol Interact; 2024 Mar; 391():110909. PubMed ID: 38340975
[TBL] [Abstract] [Full Text] [Related]
5. SHMT2 promotes papillary thyroid cancer metastasis through epigenetic activation of AKT signaling.
Sun M; Zhao M; Li R; Zhang Y; Shi X; Ding C; Ma C; Lu J; Yue X
Cell Death Dis; 2024 Jan; 15(1):87. PubMed ID: 38272883
[TBL] [Abstract] [Full Text] [Related]
6. Cell-free DNA fragmentomics and second malignant neoplasm risk in patients with pten hamartoma tumor syndrome.
Liu D; Yehia L; Dhawan A; Ni Y; Eng C
Cell Rep Med; 2024 Feb; 5(2):101384. PubMed ID: 38242121
[TBL] [Abstract] [Full Text] [Related]
7. Utilizing pten immunohistochemistry as a screening test for Cowden syndrome.
Hartsough E; DeSimone MS; Lorenzo ME; Dias-Santagata D; Nose V; Hoang MP
Am J Clin Pathol; 2024 May; 161(5):490-500. PubMed ID: 38206110
[TBL] [Abstract] [Full Text] [Related]
8. Genetic predisposition to differentiated thyroid cancer in the Polish population.
Borowczyk M; Sypniewski M; Szyda J; Braszka M; Ziemnicka K; Ruchała M; Oszywa M; Król ZJ; Dobosz P
Pol Arch Intern Med; 2024 Mar; 134(3):. PubMed ID: 38165228
[TBL] [Abstract] [Full Text] [Related]
9. Long non-coding RNA EGOT is associated with
Wang M; Wei Z; Wang S; Feng W; Shang L; Sun X
Aging (Albany NY); 2023 Nov; 15(22):13542-13557. PubMed ID: 38006396
[TBL] [Abstract] [Full Text] [Related]
10. USP10 suppresses ABCG2-induced malignant characteristics of doxorubicin-resistant thyroid cancer by inhibiting PI3K/AKT pathway.
Sun J; Xiang Q; Ding D; Yan N
J Bioenerg Biomembr; 2023 Dec; 55(6):457-466. PubMed ID: 37919637
[TBL] [Abstract] [Full Text] [Related]
11. Differential cell cycle checkpoint evasion by pten germline mutations associated with dichotomous phenotypes of cancer versus autism spectrum disorder.
Hitomi M; Venegas J; Kang SC; Eng C
Oncogene; 2023 Dec; 42(50):3698-3707. PubMed ID: 37907589
[TBL] [Abstract] [Full Text] [Related]
12. HHV-6A Infection of Papillary thyroid cancer Cells Induces Several Effects Related to cancer Progression.
Mardente S; Romeo MA; Asquino A; Po A; Gilardini Montani MS; Cirone M
Viruses; 2023 Oct; 15(10):. PubMed ID: 37896899
[TBL] [Abstract] [Full Text] [Related]
13. Anaplastic thyroid cancer:Improved understanding of what remains a deadly disease.
Cleere EF; Prunty S; O'Neill JP
Surgeon; 2024 Feb; 22(1):e48-e53. PubMed ID: 37866980
[TBL] [Abstract] [Full Text] [Related]
14. TRIP6 disrupts tight junctions to promote metastasis and drug resistance and is a therapeutic target in colorectal cancer.
Gou H; Wong CC; Chen H; Shang H; Su H; Zhai J; Liu W; Liu W; Sun D; Wang X; Yu J
Cancer Lett; 2023 Dec; 578():216438. PubMed ID: 37827326
[TBL] [Abstract] [Full Text] [Related]
15. Analysis of clinicopathological characteristics and prognostic factors of early-stage human epidermal growth factor receptor 2 (HER2)-low breast cancer: Compared with HER2-0 breast cancer.
Wu Q; Yang F; Liu Y; Zhang H; Zhang S; Xin L; Xu L
Cancer Med; 2023 Oct; 12(19):19560-19575. PubMed ID: 37772432
[TBL] [Abstract] [Full Text] [Related]
16. Detection and yield of thyroid cancer surveillance in adults with pten hamartoma tumour syndrome.
Drissen MMCM; Vos JR; Netea-Maier RT; Gotthardt M; Hoogerbrugge N
Endocr Relat Cancer; 2023 Oct; 30(10):. PubMed ID: 37451289
[TBL] [Abstract] [Full Text] [Related]
17. Case Report - Multinodular goiter in a patient with Congenital Hypothyroidism and Bannayan-Riley-Ruvalcaba syndrome: the possible synergic role of TPO and pten mutation.
Vincenzi G; Petralia IT; Abbate M; Tarantola G; Meroni SLC; Maggiore R; Mari G; Patricelli MG; Schiavo Lena M; Barera G; Vigone MC
Front Endocrinol (Lausanne); 2023; 14():1205785. PubMed ID: 37361526
[TBL] [Abstract] [Full Text] [Related]
18. Non-hyalinizing trabecular thyroid adenoma: a novel thyroid tumor with diagnostic pitfalls of hyalinizing trabecular adenoma and medullary thyroid carcinoma.
Hirokawa M; Matsuse M; Mitsutake N; Suzuki A; Higuchi M; Hayashi T; Kamma H; Miyauchi A; Akamizu T
Diagn Pathol; 2023 Jun; 18(1):74. PubMed ID: 37340328
[TBL] [Abstract] [Full Text] [Related]
19. The mitochondrial genome as a modifier of autism versus cancer phenotypes in
Wei R; Yehia L; Ni Y; Eng C
HGG Adv; 2023 Jul; 4(3):100199. PubMed ID: 37216009
[TBL] [Abstract] [Full Text] [Related]
20. p53 and pten expression evaluation with molecular evident recent criteria in laryngeal carcinoma.
Tan A; Eskiizmir G; Kamiloglu U; Sarioglu S
Medicine (Baltimore); 2023 May; 102(19):e33676. PubMed ID: 37171328
[TBL] [Abstract] [Full Text] [Related]
[Next]